​

Syros Pharmaceuticals Ownership | Who Owns Syros Pharmaceuticals?

OverviewForecastFinancialsChartTranscripts

Syros Pharmaceuticals Ownership Summary

Syros Pharmaceuticals is owned by 1.18% institutional investors, 0.76% insiders, and 98.06% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of SYRS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.44% of its assets in Syros Pharmaceuticals shares.

SYRS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSyros Pharmaceuticals1.18%0.76%98.06%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Tower research capital llc (trc)---
Sound income strategies---
Two sigma securities---
Federation des caisses desjardins du quebec---
Clarius group---
Baader bank aktiengesellschaft---
Steward partners investment advisory---
Advisor group---
Activest wealth management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Tower research capital llc (trc)---
Sound income strategies---
Two sigma securities---
Federation des caisses desjardins du quebec---
Clarius group---
Baader bank aktiengesellschaft---
Steward partners investment advisory---
Advisor group---
Activest wealth management---

Top Buyers

HolderShares% AssetsChange
Steward partners investment advisory---8.00
Truvestments capital---10.00
Psi advisors---13.00
Sound income strategies---76.00
Activest wealth management---87.00

Top Sellers

HolderShares% AssetsChange
Bain capital life sciences investors---2.75M
Blackrock funding, inc. /de---277.25K
Vanguard group---268.15K
Omega fund management---251.27K
Geode capital management---196.25K

Sold Out

HolderChange
Steward partners investment advisory-8.00
Truvestments capital-10.00
Psi advisors-13.00
Sound income strategies-76.00
Activest wealth management-87.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254-91.49%462,954-91.13%10.67%2-88.24%1-88.89%
Dec 31, 202447-31.88%5,217,717-72.45%130.57%17-32.00%9-40.00%
Sep 30, 202469-5.48%18,942,451-7.07%481.79%25-16.67%1525.00%
Jun 30, 202473-6.41%20,382,905-2.55%511.80%30-30.23%1233.33%
Mar 31, 20247827.87%20,916,1778.66%531.26%4334.38%9-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv654.18K2.44%-
Kennedy Micro Cap328.08K1.22%1.64K
Vanguard Institutional Extnd Mkt Idx Tr257.63K0.96%-
Fidelity Extended Market Index97.61K0.36%-1.06K
Bridgeway Ultra-Small Company Market50.67K0.19%-
Kennedy Micro Cap Opportunities47.18K0.18%170.00
iShares Micro-Cap ETF45.83K0.17%-
BlackRock Extended Equity Market K45.36K0.17%-19.00
Extended Equity Market Fund K44.74K0.17%-616.00
Fidelity Total Market Index39.83K0.15%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 02, 2024Simonian Nancy A-Sell$10.02K
Nov 25, 2024Simonian Nancy A-Sell$35.74K
Nov 18, 2024Stephens Kristin Chief Development OfficerSell$7.95K
Nov 18, 2024Roth David Chief Medical OfficerSell$2.38K
Nov 19, 2024Quirk Gerald E Chief Legal & Compliance OfficSell$10.32K

Insider Transactions Trends

DateBuySell
2024 Q4-7
2024 Q35-
2024 Q2-3
2024 Q1--
2023 Q412

SYRS Ownership FAQ

Who Owns Syros Pharmaceuticals?

Syros Pharmaceuticals shareholders are primarily institutional investors at 1.18%, followed by 0.76% insiders and 98.06% retail investors. The average institutional ownership in Syros Pharmaceuticals's industry, Biotech Stocks , is 63.84%, which Syros Pharmaceuticals falls below.

Who owns the most shares of Syros Pharmaceuticals?

Syros Pharmaceuticals’s largest shareholders are Geode capital management (0 shares, 0%), Tower research capital llc (trc) (0 shares, 0%), and Sound income strategies (0 shares, 0%). Together, they hold 0% of Syros Pharmaceuticals’s total shares outstanding.

Does Blackrock own Syros Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Syros Pharmaceuticals.

Who is Syros Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Geode capital management is Syros Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Syros Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Syros Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Syros Pharmaceuticals shares, with 2.44% of its total shares outstanding invested in 654.18K Syros Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools